Go Pro

Kewaunee Scientific (KEQU) Competitors

Kewaunee Scientific logo
$36.02 +1.49 (+4.33%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$35.93 -0.09 (-0.26%)
As of 09/11/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KEQU vs. SENS, OFIX, MOBI, RCEL, and TMCI

Should you buy Kewaunee Scientific stock or one of its competitors? Kewaunee Scientific's main competitors and comparable companies include Senseonics Holdings, Inc. Common Stock (SENS), Orthofix Medical (OFIX), Mobia Medical (MOBI), Avita Medical (RCEL), and Treace Medical Concepts (TMCI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kewaunee Scientific compare to Senseonics Holdings, Inc. Common Stock?

Kewaunee Scientific (NASDAQ:KEQU) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Kewaunee Scientific has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market.

Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, indicating a potential upside of 97.47%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Kewaunee Scientific had 3 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 7 mentions for Kewaunee Scientific and 4 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.99 beat Kewaunee Scientific's score of 0.87 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Senseonics Holdings, Inc. Common Stock
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kewaunee Scientific has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$277.22M0.37$9.62M$2.7613.05
Senseonics Holdings, Inc. Common Stock$48.55M7.50-$69.11M-$2.23N/A

Kewaunee Scientific has a net margin of 2.97% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Kewaunee Scientific's return on equity of 11.75% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific2.97% 11.75% 4.78%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

Summary

Kewaunee Scientific beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Orthofix Medical?

Orthofix Medical (NASDAQ:OFIX) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Orthofix Medical has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

Orthofix Medical presently has a consensus price target of $14.75, indicating a potential upside of 65.17%. Given Orthofix Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Orthofix Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Kewaunee Scientific had 5 more articles in the media than Orthofix Medical. MarketBeat recorded 7 mentions for Kewaunee Scientific and 2 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.77 beat Kewaunee Scientific's score of 0.87 indicating that Orthofix Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Kewaunee Scientific
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kewaunee Scientific has a net margin of 2.97% compared to Orthofix Medical's net margin of -7.41%. Kewaunee Scientific's return on equity of 11.75% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.41% -14.05% -7.17%
Kewaunee Scientific 2.97%11.75%4.78%

Kewaunee Scientific has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$833.19M0.44-$92.19M-$1.54N/A
Kewaunee Scientific$277.22M0.37$9.62M$2.7613.05

Summary

Kewaunee Scientific beats Orthofix Medical on 9 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Mobia Medical?

Mobia Medical (NASDAQ:MOBI) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Kewaunee Scientific has a net margin of 2.97% compared to Mobia Medical's net margin of 0.00%. Kewaunee Scientific's return on equity of 11.75% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia MedicalN/A N/A N/A
Kewaunee Scientific 2.97%11.75%4.78%

32.7% of Kewaunee Scientific shares are owned by institutional investors. 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Kewaunee Scientific had 5 more articles in the media than Mobia Medical. MarketBeat recorded 7 mentions for Kewaunee Scientific and 2 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 1.45 beat Kewaunee Scientific's score of 0.87 indicating that Mobia Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kewaunee Scientific
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mobia Medical currently has a consensus target price of $20.75, indicating a potential upside of 107.29%. Given Mobia Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Mobia Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than Mobia Medical. Mobia Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M10.40-$46.50M-$20.18N/A
Kewaunee Scientific$277.22M0.37$9.62M$2.7613.05

Summary

Kewaunee Scientific beats Mobia Medical on 10 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Avita Medical presently has a consensus price target of $11.40, indicating a potential upside of 15.38%. Given Avita Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Avita Medical is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avita Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Kewaunee Scientific had 5 more articles in the media than Avita Medical. MarketBeat recorded 7 mentions for Kewaunee Scientific and 2 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.62 beat Kewaunee Scientific's score of 0.87 indicating that Avita Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avita Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Kewaunee Scientific
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kewaunee Scientific has a net margin of 2.97% compared to Avita Medical's net margin of -56.96%. Kewaunee Scientific's return on equity of 11.75% beat Avita Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Avita Medical-56.96% N/A -78.53%
Kewaunee Scientific 2.97%11.75%4.78%

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Kewaunee Scientific has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avita Medical$71.61M4.25-$48.59M-$1.44N/A
Kewaunee Scientific$277.22M0.37$9.62M$2.7613.05

Avita Medical has a beta of 2.02, suggesting that its share price is 102% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

Summary

Kewaunee Scientific beats Avita Medical on 10 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

Treace Medical Concepts has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Kewaunee Scientific had 4 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Kewaunee Scientific and 3 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 1.56 beat Kewaunee Scientific's score of 0.87 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Treace Medical Concepts
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Kewaunee Scientific
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kewaunee Scientific has a net margin of 2.97% compared to Treace Medical Concepts' net margin of -28.99%. Kewaunee Scientific's return on equity of 11.75% beat Treace Medical Concepts' return on equity.

Company Net Margins Return on Equity Return on Assets
Treace Medical Concepts-28.99% -71.37% -30.49%
Kewaunee Scientific 2.97%11.75%4.78%

Treace Medical Concepts currently has a consensus target price of $5.17, indicating a potential upside of 14.63%. Given Treace Medical Concepts' higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treace Medical Concepts
2 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.86
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treace Medical Concepts$205.31M1.43-$59M-$0.93N/A
Kewaunee Scientific$277.22M0.37$9.62M$2.7613.05

Summary

Kewaunee Scientific beats Treace Medical Concepts on 9 of the 16 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KEQU vs. The Competition

MetricKewaunee ScientificHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$99.06M$5.44B$7.15B$12.72B
Dividend YieldN/A1.79%2.56%11.15%
P/E Ratio13.0525.09275.2425.29
Price / Sales0.3782.90656.0298.94
Price / Cash5.8032.5377.0451.44
Price / Book1.345.9710.336.20
Net Income$9.62M$150.75M$3.50B$358.50M
7 Day Performance-2.61%-2.83%-3.32%-2.35%
1 Month Performance-0.57%-3.09%-0.41%-2.77%
1 Year Performance-15.02%9.34%19.21%7.63%

Kewaunee Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KEQU
Kewaunee Scientific
0.9375 of 5 stars
$36.02
+4.3%
N/A-16.4%$99.06M$277.22M13.051,231
SENS
Senseonics Holdings, Inc. Common Stock
3.74 of 5 stars
$9.38
+1.6%
$17.20
+83.4%
N/A$385.84M$35.26MN/A90
OFIX
Orthofix Medical
3.135 of 5 stars
$9.43
+0.4%
$14.75
+56.4%
-40.5%$382.48M$822.31MN/A1,605
MOBI
Mobia Medical
4.0955 of 5 stars
$11.45
+2.6%
$20.75
+81.2%
N/A$371.53M$45.28MN/AN/A
RCEL
Avita Medical
2.1559 of 5 stars
$10.07
-0.3%
$11.40
+13.2%
+125.6%$310.85M$75.63MN/A130

Related Companies and Tools


This page (NASDAQ:KEQU) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners